United States · FDA National Drug Code directory
Ipratropium Bromide and Albuterol Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-173_d98264d7-80fe-445f-ac85-2da23d9c374f
- Product NDC
- 69097-173
- Form
- SOLUTION
- Composition / generic term
- Ipratropium Bromide and Albuterol Sulfate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071231
- Source listing expiry
- 20271231
Source-listed ingredients
- ALBUTEROL SULFATE — 2.5 mg/3mL
- IPRATROPIUM BROMIDE — .5 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (69097-173-53) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL · 69097-173-53
- 12 POUCH in 1 CARTON (69097-173-64) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL · 69097-173-64
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →